HomeNewsWorldSunder Pichai, Punit Renjen and Shantanu Narayen join steering committee of Global Task Force on Pandemic Response

Sunder Pichai, Punit Renjen and Shantanu Narayen join steering committee of Global Task Force on Pandemic Response

.Others who were added to the list on Thursday are Mark Suzman, CEO, Bill & Melinda Gates Foundation; Joshua Bolten, president and CEO, Business Roundtable and Suzanne Clark, president and CEO, US Chamber of Commerce.

May 07, 2021 / 08:04 IST

Three Indian-American CEOs Sunder Pichai from Google, Punit Renjen from Deloitte and Shantanu Narayen from Adobe have joined the steering committee of the Global Task Force on Pandemic Response, which is overseeing an unprecedented corporate sector initiative to help India successfully fight COVID19.

The names of the three Indian-American CEOs were added to the list of the steering committee on Thursday.

The three CEOs have been active in organising US companies’ response to the COVID-19 crisis in India.

Others who were added to the list on Thursday are Mark Suzman, CEO, Bill & Melinda Gates Foundation; Joshua Bolten, president and CEO, Business Roundtable and Suzanne Clark, president and CEO, US Chamber of Commerce.

The task force is a newly formed public-private partnership organised by the US Chamber of Commerce and supported by Business Roundtable. It is working with the Chamber’s US-India Business Council and the US-India Strategic Partnership Forum to take immediate actions to help address the COVID-19 surge in India.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The US corporate sector so far has committed more than 25,000 oxygen concentrators for India. The first 1,000 oxygen concentrators, provided by Deloitte, arrived in India on April 25, with critical logistical support from FedEx.

These concentrators will be shipped to designated healthcare facilities for immediate use, the task force said.

The first shipment of ventilators landed in India early this week. All 1,000 ventilators are expected to reach India by June 3.

Medtronic will provide end-to-end support for the initiative.

As many as 16 businesses have joined the task force’s ventilator initiative.

Together these businesses will provide over USD 30 million in support for India’s healthcare response – joining the dozens of businesses which have pledged their support in efforts to provide oxygen concentrators, develop information and best practices to support employees in India and more, the task force said.

According to the task force, while the country has been reporting over 4,00,000 cases daily, the actual case rate in India is estimated to be much higher.

Experts forecast the crisis will only worsen, with India’s peak not expected until mid-May, it said.

Other members of the steering committee include Julie Sweet, CEO of Accenture; Andy Jassy, the CEO of Amazon, Tim Cook, the CEO of Apple, Brian Moynihan, Chairman of the Board and CEO, Bank of America; Raj Subramaniam, president FedEx; and Arvind Krishna, Chairman and CEO, IBM.

Gail McGovern, president and CEO, American Red Cross; Mike Parra, CEO Americas, DHL Express; Jim Fitterling, Chairman and CEO, Dow; Alex Gorsky, chairman of the Board and CEO, Johnson & Johnson; Michael Miebach, CEO, Mastercard; Geoff Martha, chairman and CEO, Medtronic; Brad Smith, president, Microsoft; Ramon Laguarta, Chairman of the Board and CEO, PepsiCo; Carol Tomé, CEO, UPS; Sanjay Poonen, COO, VMware; and Judith McKenna, President and CEO, Walmart International are also members of the task force.

Till date, over 45 US businesses and associations have contributed to the Global Task Force’s activities.

While the task force is focusing initial efforts on the pressing need in India, additional working groups will be formed to address COVID-19 surges in other countries.

Through its steering committee, the task force will work to concentrate efforts where corporate support will be most beneficial, it said.

PTI
first published: May 7, 2021 08:05 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347